Effectivenessof intranasal vs intravenous dexmedetomidine infusion providing induced hypotension in functional endoscopic sinus surgery(FESS)-A clinical trial

comparison of intranasal and intravenous dexmedetomidine infusion in providing induced hypotension in functional endoscopic sinus surgery(FESS)-A Randomised double blind trial - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067369

Enrollment

Registered

2024-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H60-H95- Diseases of the ear and mastoid process

Interventions

Intervention1: Intravenous Dexmedetomidine: Inj. Dexmedetomidine at dose of 1 mcg/kg bolus,before 30min of induction over a period of 10min in 0.9% 100ml saline,followed by infusion 0.4mcg/kg/hr 100

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to ASA 1 and ASA 2 physical status, surgery duration of less than 3hours

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
To compare the Target MAP to achieve bloodless field in the two group of patients(IV &IN Dexmedotimine group)Timepoint: At baseline,5mins,10mins,15mins,30mins, 1hours,1:30hours,2hours,2:30hours,3hours and postoperatively 30min,1hour,1:30hour,2hours	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDR RAM PANDIAN G

Sri Balaji vidyapeeth university

drgayatrimishra@gmail.com9894354068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026